Earl Martin Douglas insider trades

Open-market stock purchases and sales by Earl Martin Douglas, SVP, General Counsel at Allogene Therapeutics, Inc, from SEC Form 4 filings since Jan 2, 2010.

Recent trades

DateStockTradeValue
Aug 21, 2026ALLO Allogene Therapeutics, IncSold$63K
Feb 2, 2026ALLO Allogene Therapeutics, IncBought (not open market)—
Feb 2, 2026ALLO Allogene Therapeutics, IncBought (not open market)—
Feb 2, 2026ALLO Allogene Therapeutics, IncSold$40.3K

Companies traded

  • ALLO Allogene Therapeutics, Inc: 3 sales, last Aug 21, 2026
  • BMTI Biomimetic Therapeutics, Inc: 29 sales, last Mar 28, 2012

Get free alerts when Earl Martin Douglas files a new trade →